Perrier never had what it took to be a champion racehorse. In the brutally competitive world of thoroughbred racing, where fractions of seconds and perfect proportions separate winners from also-rans, this horse simply didn't measure up.

"He was a failed racehorse," said Ben Noren, founder of CellDrop Biosciences, a University of Wyoming spinoff company developing next-generation stem cell therapies.

"As a foal, he weeded out because he just wasn't as big and strong as the other horses — didn't have the right body type," said Noren.

"His name is Perry. Short for Perrier, as in the drink," Noren explained, referring to the popular brand of sparkling water from France sold in an iconic green bottle.

If CellDrop's clinical trials go as planned, stem cells collected from Perrier will go in

See Full Page